The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis.
Authors:
- D J LoskutoffDLD J Loskutoff
- 1 September 1997
- journal article
- Vol. 151 (3) , 725-34
Abstract
Quantitative reverse transcription polymerase chain reaction and in situ hybridization were employed to investigate the expression of tissue-type and urokinase-type plasminogen activators (t-PA and u-PA, respectively), of their specific inhibitor (PAI-1), and of the procoagulant molecule tissue factor (TF) in tissues from mice that develop autoimmune disease (MRL lpr/lpr). A dramatic increase in PAI-1 activity in plasma and in PAI-1 mRNA in the kidneys was observed in these mice, and this increase appeared to correlate with the progression of lupus nephritis. The increase in PAI-1 mRNA was relatively specific for the kidney as little or no change was observed in most other tissues. One exception was the brain where PAI-1 mRNA was also significantly higher in the diseased mice. In addition to these changes in PAI-1, decreases in u-PA mRNA and increases in TF mRNA were demonstrated in kidneys from the lupus-prone mice. These changes also correlated with the development of lupus nephritis and with spontaneous glomerular and peritubular fibrin deposition in the nephritic kidney. In this regard, the MRL lpr/lpr mice were found to be considerably more sensitive to endotoxin than the normal controls, developing fibrin deposits in the kidneys and other tissues at 10- to 20-fold lower concentrations of this toxic agent. The increase in PAI-1 and TF mRNAs and the decrease in u-PA mRNA in the kidneys of MRL lpr/lpr mice suggests that changes in the expression of these genes may promote the formation of microthrombi and thus contribute to the progression of lupus nephritis in this model.Keywords
This publication has 38 references indexed in Scilit:
- Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritisKidney International, 1995
- Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat.Journal of Histochemistry & Cytochemistry, 1995
- Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritisKidney International, 1995
- Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.BMJ, 1990
- Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits.Journal of Clinical Investigation, 1988
- Glomerular procoagulant activity in human proliferative glomerulonephritis.Journal of Clinical Investigation, 1988
- Expression of macrophage procoagulant activity in murine systemic lupus erythematosus.Journal of Clinical Investigation, 1986
- Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus.Journal of Clinical Investigation, 1985
- Effects of fibrinogen degradation products on glomerular mesangial cells in cultureKidney International, 1984
- RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)Medicine, 1978